Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Hoes, JoskeWoestenberg, Petra J
Bogaards, Johannes A
King, Audrey J
de Melker, Hester E
Berkhof, Johannes
Hoebe, Christian J P A
van der Sande, Marianne A B
van Benthem, Birgit H B
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects.Published in
Clin infect Dis 2021; 72(5):e103-e111PMID
33249475ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciaa1770
Scopus Count
Collections
Related articles
- Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
- Authors: Woestenberg PJ, Bogaards JA, King AJ, Leussink S, van der Sande MA, Hoebe CJ, van Benthem BH, Medical Microbiological Laboratories and the Public Health Services
- Issue date: 2019 Jun 1
- HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
- Authors: Woestenberg PJ, van Benthem BHB, Bogaards JA, King AJ, van der Klis FRM, Pasmans H, Leussink S, van der Sande MAB, Hoebe CJPA, Medical Microbiological Laboratories, the Public Health Services
- Issue date: 2020 Apr 9
- No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
- Authors: Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH, Medical Microbiological Laboratories, Public Health Services
- Issue date: 2017 Apr
- Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
- Authors: Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK
- Issue date: 2017 Jan
- Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
- Authors: Woestenberg PJ, King AJ, van Benthem BHB, Donken R, Leussink S, van der Klis FRM, de Melker HE, van der Sande MAB, Hoebe CJPA, Bogaards JA, Medical Microbiological Laboratories and the Public Health Services
- Issue date: 2018 Jan 4